{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05864521",
            "orgStudyIdInfo": {
                "id": "23-000874"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Beetroot Juice and Sleep",
            "officialTitle": "Effects of Nocturnal Inorganic Nitrate Supplementation on Physiological Function",
            "therapeuticArea": [
                "Other"
            ],
            "study": "beetroot-juice-and-sleep"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-05-09",
            "studyFirstSubmitQcDate": "2023-05-09",
            "studyFirstPostDateStruct": {
                "date": "2023-05-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-02",
            "lastUpdatePostDateStruct": {
                "date": "2023-10-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Virend Somers, MD, PhD",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to investigate the effects of acute inorganic nitrate supplementation (with beetroot) on the regulation of sleep and neurovascular physiology."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy"
            ],
            "keywords": [
                "Blood Pressure",
                "Sleep"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Active Beetroot Juice Supplement (aBRJ) then Placebo Beetroot Juice Supplement (pBRJ)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Subjects randomized to this arm of the study will have aBRJ administered during Visit 2 and then pBRJ administered during Visit 3.",
                    "interventionNames": [
                        "Dietary Supplement: Active Beetroot Juice Supplement (aBRJ)",
                        "Dietary Supplement: Placebo Beetroot Juice Supplement (pBRJ)"
                    ]
                },
                {
                    "label": "Placebo Beetroot Juice Supplement (pBRJ) then Active Beetroot Juice Supplement (aBRJ)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Subjects randomized to this arm of the study will have pBRJ administered during Visit 2 and then aBRJ administered during Visit 3.",
                    "interventionNames": [
                        "Dietary Supplement: Active Beetroot Juice Supplement (aBRJ)",
                        "Dietary Supplement: Placebo Beetroot Juice Supplement (pBRJ)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Active Beetroot Juice Supplement (aBRJ)",
                    "description": "aBRJ will consist of 70ml concentrated beetroot juice with 6.45-7.26mmol inorganic nitrate (range for inter-batch variability) taken orally.",
                    "armGroupLabels": [
                        "Active Beetroot Juice Supplement (aBRJ) then Placebo Beetroot Juice Supplement (pBRJ)",
                        "Placebo Beetroot Juice Supplement (pBRJ) then Active Beetroot Juice Supplement (aBRJ)"
                    ]
                },
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Placebo Beetroot Juice Supplement (pBRJ)",
                    "description": "pBRJ will consist of 70ml concentrated beetroot juice and will be chemically devoid of inorganic nitrate taken orally.",
                    "armGroupLabels": [
                        "Active Beetroot Juice Supplement (aBRJ) then Placebo Beetroot Juice Supplement (pBRJ)",
                        "Placebo Beetroot Juice Supplement (pBRJ) then Active Beetroot Juice Supplement (aBRJ)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in the amount of time in stage three sleep",
                    "description": "Measured overnight polysomnography (PSG) used to identify sleep staging, reported in minutes",
                    "timeFrame": "Baseline, approximately 30 days, and approximately 60 days"
                },
                {
                    "measure": "Change in sleep quality",
                    "description": "Measured by Pittsburgh Sleep Quality Index which measures the severity of sleep disturbances. Possible scores range from 0 to 21 with higher scores indicating a worse outcome/more severe symptoms of sleep disturbance.",
                    "timeFrame": "Baseline, approximately 30 days, and approximately 60 days"
                },
                {
                    "measure": "Change in self-reported sleep quality",
                    "description": "Measured on a visual analog scale of 1-10, where 1 is not at all sleepy and 10 is as sleepy as you can imagine, how sleepy are you right now?",
                    "timeFrame": "Baseline, approximately 30 days, and approximately 60 days"
                },
                {
                    "measure": "Change in sleepiness",
                    "description": "Measured by the Stanford Sleepiness Scale that asks participate to rank their degree of sleepiness where 1 would indicate the subject currently feels least sleepy and 7 would indicate the subject feels the most sleepy.",
                    "timeFrame": "Baseline, approximately 30 days, and approximately 60 days"
                },
                {
                    "measure": "Change in daytime sleepiness",
                    "description": "Measured by Epworth Sleepiness Scale. The test is a list of eight situations in which you rate your tendency to become sleepy on a scale of 0, no chance of dozing, to 3, high chance of dozing. Total score is graded from 0-24. 0-7:It is unlikely that you are abnormally sleepy. 8-9:You have an average amount of daytime sleepiness. 10-15:You may be excessively sleepy depending on the situation. You may want to consider seeking medical attention. 16-24:You are excessively sleepy and should consider seeking medical attention.",
                    "timeFrame": "Baseline, approximately 30 days, and approximately 60 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in blood pressure",
                    "description": "Measured in millimeters of mercury (mmHg)",
                    "timeFrame": "Baseline, approximately 30 days, and approximately 60 days"
                },
                {
                    "measure": "Change in sympathetic nerve burst frequency",
                    "description": "Measured by Microneurography reported as number of nerve bursts per minute (burst/min)",
                    "timeFrame": "Baseline, approximately 30 days, and approximately 60 days"
                },
                {
                    "measure": "Change in sympathetic nerve burst incidence",
                    "description": "Measured by Microneurography reported as number of nerve burst per 100 heart beats (burst/100 heart beats)",
                    "timeFrame": "Baseline, approximately 30 days, and approximately 60 days"
                },
                {
                    "measure": "Change in sympathetic nerve burst amplitude (AU)",
                    "description": "Measured by Microneurography reported in arbitrary units (AU)",
                    "timeFrame": "Baseline, approximately 30 days, and approximately 60 days"
                },
                {
                    "measure": "Change in total muscle sympathetic nerve activity (MSNA)",
                    "description": "Measured by Microneurography reported burst arbitrary units per minute (AU/min)",
                    "timeFrame": "Baseline, approximately 30 days, and approximately 60 days"
                },
                {
                    "measure": "Change in arterial stiffness",
                    "description": "Measured by applanation tonometry reported as aortic pulse wave velocity (m/sec)",
                    "timeFrame": "Baseline, approximately 30 days, and approximately 60 days"
                },
                {
                    "measure": "Change in endothelial function",
                    "description": "Ultrasound assessment of flow-mediated vasodilation of the brachial artery. Brachial artery diameter and blood velocity will be measured after deflation to measure endothelial function.",
                    "timeFrame": "Baseline, approximately 30 days, and approximately 60 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* 18-30 or 65-80 years of age\n\nExclusion Criteria:\n\n* Coronary artery disease\n* Heart failure\n* Pregnancy\n* Diabetes\n* Sleep disorders\n* Shift workers\n* Individuals who typically go to sleep after midnight\n* Individuals who traveled across \u22652 time zones within one week of study visits\n* Individuals with a history frequent kidney stones\n* BMI \u226535.0kg/m2\n* Use of nicotine-containing products within the two years preceding study visits\n* Use of allopurinol, proton pump inhibitors, or other medications/supplements which interfere with the nitrate-nitrite-nitric oxide pathway or outcome measures",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Joshua Bock, PhD",
                    "role": "CONTACT",
                    "phone": "(507) 422-0768",
                    "email": "Bock.Joshua@mayo.edu"
                },
                {
                    "name": "Virend Somers, MD, PhD",
                    "role": "CONTACT",
                    "phone": "(507) 255-1144",
                    "email": "Somers.Virend@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Virend Somers, MD, PhD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic in Rochester",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joshua Bock, PhD",
                            "role": "CONTACT",
                            "phone": "507-422-0768",
                            "email": "bock.joshua@mayo.edu"
                        },
                        {
                            "name": "Virend Somers, MD, PhD",
                            "role": "CONTACT",
                            "phone": "(507) 255-1144",
                            "email": "Somers.Virend@mayo.edu"
                        },
                        {
                            "name": "Virend Somers, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}